Lymphoma, Mucosa-Associated Lymphoid Tissue

Also known as: Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT) / Mucosa Associated Lymphoid Tissue (MALT) Lymphoma / Lymphoma of Mucosa-Associated Lymphoid Tissue / Mucosal-Associated Lymphoid Tissue Lymphoma / Mucosa-Associated Lymphoid Tissue Lymphoma / Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] / Lymphoma, B-Cell, Marginal Zone / MALT lymphoma / Mucosa-associated lymphoma (disorder) / Marginal zone B-cell lymphoma (morphologic abnormality) / Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (disorder) / Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (morphologic abnormality) / Primary cutaneous marginal zone B-cell lymphoma (disorder) / Primary cutaneous marginal zone B-cell lymphoma (morphologic abnormality) / Marginal zone lymphoma / Marginal zone lymphoma (disorder) / Bronchus-associated lymphoid tissue lymphoma / BALT lymphoma / Small cell B-cell lymphoma / Nodal marginal zone B-cell lymphoma (disorder) / Nodal marginal zone B-cell lymphoma / Monocytoid B-cell lymphoma (disorder) / Nodal marginal zone B-cell lymphomas / Nodal marginal zone B-cell lymphoma NOS / Nodal marginal zone B-cell lymphoma (morphologic abnormality)

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00188Bortezomib2Completed1
DB00188Bortezomib2Terminated1
DB00242Cladribine2Completed1
DB01211Clarithromycin2Active Not Recruiting1
DB01234Dexamethasone2Completed1
DB00480Lenalidomide2Active Not Recruiting1
DB00480Lenalidomide2Completed2
DB00073Rituximab2Completed3
DB00291Chlorambucil3Completed1
DB00073Rituximab3Active Not Recruiting1
DB00073Rituximab3Completed1